Statins and Breast Cancer Biomarkers
Public ClinicalTrials.gov record NCT00914017. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00914017
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- University of Vermont
- Other
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- Atorvastatin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 35 Years to 55 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2004
- Primary completion
- Nov 30, 2010
- Completion
- Not listed
- Last update posted
- Feb 10, 2010
Started 2005
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94143 | Recruiting |
| Delaware Christiana Care CCOP, Helen F. Graham Cancer Center | Newark | Delaware | 19718 | Recruiting |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | Recruiting |
| Southern Nevada Cancer Research Foundation | Las Vegas | Nevada | 89106 | Recruiting |
| Duke University | Durham | North Carolina | 27705 | Recruiting |
| Southeastern Medical Oncology Center | Goldsboro | North Carolina | 27534 | Recruiting |
| Vermont Cancer Center | Burlington | Vermont | 05405 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00914017, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 10, 2010 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00914017 live on ClinicalTrials.gov.